Chargement en cours...
Predictors of Successful Cardioversion with Vernakalant in Patients with Recent‐Onset Atrial Fibrillation
BACKGROUND: Vernakalant is a novel atrial‐selective antiarrhythmic drug able to convert recent‐onset atrial fibrillation (AF) with reportedly low proarrhythmic risk. Successful cardioversion predictors are largely unknown. We sought to evaluate clinical and electrocardiographic predictors of cardiov...
Enregistré dans:
| Publié dans: | Ann Noninvasive Electrocardiol |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6931769/ https://ncbi.nlm.nih.gov/pubmed/25040826 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/anec.12178 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|